These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27005869)

  • 1. The proposed change to primary HPV screening in New Zealand: reasons for caution.
    Fitzgerald P; Cox B; Miller A; Hill S; Reid J
    N Z Med J; 2016 Mar; 129(1431):18-22. PubMed ID: 27005869
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea.
    Jung S; Lee B; Lee KN; Kim Y; Oh EJ
    Arch Pathol Lab Med; 2016 Mar; 140(3):276-80. PubMed ID: 26927723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
    Coppock JD; Willis BC; Stoler MH; Mills AM
    Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.
    Boehmer G; Wang L; Iftner A; Holz B; Haedicke J; von Wasielewski R; Martus P; Iftner T
    BMC Infect Dis; 2014 Dec; 14():674. PubMed ID: 25487281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
    Lorenzi AT; Fregnani JH; Possati-Resende JC; Antoniazzi M; Scapulatempo-Neto C; Syrjänen S; Villa LL; Longatto-Filho A
    Cancer Cytopathol; 2016 Aug; 124(8):581-8. PubMed ID: 27070446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
    Narkcham S; Mody DR; Jones A; Thrall MJ
    J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cytology in the 21st Century: The Integration of Cells and Molecules.
    Bergeron C; von Knebel Doeberitz M
    Acta Cytol; 2016; 60(6):540-542. PubMed ID: 27788516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
    Ebisch RMF; Ketelaars PJW; van der Sanden WMH; Schmeink CE; Lenselink CH; Siebers AG; Massuger LFAG; Melchers WJG; Bekkers RLM
    PLoS One; 2018; 13(10):e0206219. PubMed ID: 30356297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
    Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
    J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators.
    Placidi A; Capparucci P; Di Luzio A; Manca G; Mania E; Filippini T; Giorgi Rossi P
    Acta Cytol; 2016; 60(5):458-464. PubMed ID: 27504992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
    J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HIV mRNA in routine liquid-based cytology specimens of HIV-infected women.
    Brito MJ; Quintas A; Sequeira P; Alves AT; Martins C; Félix A
    Cytopathology; 2021 Sep; 32(5):640-645. PubMed ID: 33914385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.